Ligand (LGND) Breakout! | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Ligand (LGND) Breakout!

An SI Board Since September 1996

Posts	SubjectMarks	Bans	Symbol
32384	154	0	LGND

Emcee: Henry Niman	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
30584	conference call lgnd will be presenting at an investor conference. does it	ted indig	-	3/25/2000
30583	Ligand has scheduled a special conference call over the internet at BestCalls a	ewolf	-	3/25/2000
30582	Sorry for my untimely response. As some have noted, by board participation has	Henry Niman	-	3/22/2000
30581	Henry, Please do what you do so well and put todays announcement in perspectiv	smh	-	3/21/2000
30580	Excellent news from LGND this morning.........................Ligand Advances L	Arthur Radley	-	3/21/2000
30579	LGND News biz.yahoo.com	Mudcat	-	3/21/2000
30578	( BW)(CA-LIGAND-PHARMACEUTICALS)(LGND) Targretin Capsules Benefit Patients with	celeryroot.com	-	3/13/2000
30577	The current issue of Kiplinger's magazine mentions LGND in a very positive	Arthur Radley	-	3/10/2000
30576	interested in comments on how AXPH SERM program relates to LGND's. Henry (a	bob zagorin	-	3/10/2000
30575	tough crowd. i thought the Q report was pretty good. i love reading the synopsi	bob zagorin	-	3/10/2000
30574	I told Hank weeks ago that Panretin was a flop. I guess this just proves I was	Mudcat	-	3/10/2000
30573	If 1999 sales revenue totaled $11.3 M, but only $2.1 M for the fourth Q....not	Arthur Radley	-	3/10/2000
30572	Bob....Sales numbers still look anemic......a positive surprise is the reductio	Louis A. Rawden	-	3/9/2000
30571	Ligand Reports 1999 Results; Ends Year With Three FDA Product Approvals and Cas	bob zagorin	-	3/9/2000
30570	my apologies, i misunderstood your reference.	bob zagorin	-	3/7/2000
30569	bob, w/ all due respect, my note was about lgnd putting out a release while the	Skeeter Bug	-	3/6/2000
30568	skeets, with all due respect, you've been saying that for over a month incl	bob zagorin	-	3/6/2000
30567	the old saying is "get while the gettin' is good." now is just s	Skeeter Bug	-	3/6/2000
30566	Yeah ... now all we need is some news to shake things up the way ISIP did. :)	Howard S.	-	3/6/2000
30565	congrats to those that have held so far... :-) long time coming -ng-	Skeeter Bug	-	3/6/2000
30564	Elan buys cheap. They're pretty astute. Note what happened to their littl	Torben Noerup Nielsen	-	3/6/2000
30563	i don't follow LIPO so i don't know.	bob zagorin	-	3/6/2000
30562	Why is LIPO not getting much of a premium from ELN?	J Stone	-	3/6/2000
30561	Acquistion: Elan to Acquire The Liposome Company for roughly $15 1/4 per share.	bob zagorin	-	3/6/2000
30560	Looks like ELAN is doing their part to help LGND in its drive towards profitabi	J Stone	-	3/2/2000

Go to reply# or date (mm/dd/yy):